Jeffrey Enejosa

Dr. Jeffrey Enejosa has extensive work experience in the pharmaceutical and biotechnology industry, as well as in medical practice. Jeffrey is currently serving as the Vice President of Clinical Development at DICE Therapeutics, a subsidiary of Eli Lilly and Company. Previously, Dr. Enejosa held the same position at EQRx.

Before that, they worked at AbbVie, where they held various roles in clinical development, including Group Medical Director, Senior Medical Director, and Medical Director. Jeffrey also served as the Senior Director of Clinical Research at Tobira Therapeutics and as the Director of Clinical Development and Head of Drug Safety and Pharmacovigilance at Dynavax Technologies.

Prior to their industry roles, Dr. Enejosa worked as an Internal Medicine Physician at Desert AIDS Project, Callen-Lorde Community Health Center, and in their own private practice in Fort Lauderdale, FL. Jeffrey also held the position of Director of Clinical Research at Gilead Sciences and Associate Director of Medical Affairs at Bristol-Myers Squibb.

With their diverse background and extensive experience, Dr. Enejosa brings a wealth of knowledge and expertise to their role in clinical development.

Jeffrey Enejosa, MD completed their Doctor of Medicine degree at the University of the Philippines. Jeffrey also obtained a Bachelor of Science in Basic Medical Sciences from the same university. Jeffrey further pursued their education by completing a Post-Graduate Residency in Internal Medicine at the New York Medical College.